Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Gary Scheiner shares how to make your blood glucose data work for you.
Kelly shares some very positive news and highlights the latest new, cool technology to manage diabetes and obesity.
The artificial pancreas is coming – will it be connected to an iPhone? What we learned at Children with Diabetes - Focus on Technology.
Touchscreen meets insulin pump in Tandem’s new t:slim.
On February 7, the FDA cleared LifeScan’s OneTouch VerioSync blood glucose meter. It will feature wireless Bluetooth compatibility with the iPhone, allowing blood...
The newest in CGM: learn about Dexcom’s redesigned, more accurate, and sleeker G4 Platinum system.
Frequent and careful blood glucose monitoring is unquestionably useful for people who take insulin, but is monitoring necessary for all patients
In September, Medtronic and Bayer announced that Bayer's Contour Next Link meter became available to patients ordering new Medtronic Paradigm Revel insulin pumps and...
In February, Dexcom submitted an application to expand the label for the G4 Platinum CGM (continuous glucose monitor) to pediatric patients who are as young as two years...
Highlights from Maryland's back-to-back meetings.
Our trip to Berlin brought new insights on implantable GLP-1, the latest in CGM and the artificial pancreas, and debates on early insulin therapy.
The artificial pancreas in peoples’ homes at the Annual Technologies & Treatments for Diabetes Meeting in Paris.
In June 2012, Medtronic held an Investor Conference to describe its upcoming products and expectations for the next five years. One of the biggest news items for...
Ever wondered if we have it better or worse than other countries? Dr. Dorothee Deiss reveals the state of diabetes care in Germany.
Click to learn exciting news on the artificial pancreas, faster insulins, and the results of the much-anticipated ORIGIN trial.
On December 14, the FDA granted 510(k) clearance for Insulet’s next-generation, much smaller OmniPod insulin patch pump, concluding a lengthy 19-month US regulatory...
On July 13, Johnson & Johnson acquired Calibra Medical , maker of the Finesse “insulin patch-pen” for type 1 and type 2 diabetes. The slimly designed Finesse (2...
On November 28, CeQur announced that it had received CE Mark approval for its PaQ Insulin Delivery Device , allowing the product to be sold in Europe. The Swiss-based...
Over the course of their lifetimes, roughly half of all people with diabetes develop diabetic neuropathy, which affects the nerves and can cause feelings of numbness and...
On November 29, NeuroMetrix announced that it had cleared the final hurdle holding up the introduction of the Sensus Pain Management System, designed for the treatment...

Pages